These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12831340)

  • 1. A review of the clinical efficacy and tolerability of almotriptan in acute migraine.
    Dodick DW
    Expert Opin Pharmacother; 2003 Jul; 4(7):1157-63. PubMed ID: 12831340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Almotriptan: a review of its use in migraine.
    Keam SJ; Goa KL; Figgitt DP
    Drugs; 2002; 62(2):387-414. PubMed ID: 11817980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spotlight on almotriptan in migraine.
    Keam SJ; Goa KL; Figgitt DP
    CNS Drugs; 2002; 16(7):501-7. PubMed ID: 12056924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral almotriptan in the treatment of migraine: safety and tolerability.
    Dodick DW
    Headache; 2001 May; 41(5):449-55. PubMed ID: 11380642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A long-term open-label study of oral almotriptan 12.5 mg for the treatment of acute migraine.
    Mathew NT;
    Headache; 2002 Jan; 42(1):32-40. PubMed ID: 12005273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Almotriptan: an effective and well-tolerated treatment for migraine pain.
    Pascual J
    Drugs Today (Barc); 2003; 39 Suppl D():31-6. PubMed ID: 15071618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the effects of almotriptan and other triptans on clinical trial outcomes that are meaningful to patients with migraine.
    Mondell BE
    Clin Ther; 2003 Feb; 25(2):331-41. PubMed ID: 12749502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis examining the efficacy and safety of almotriptan in the acute treatment of migraine.
    Chen LC; Ashcroft DM
    Headache; 2007 Sep; 47(8):1169-77. PubMed ID: 17883521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Almotriptan is an effective and well-tolerated treatment for migraine pain: results of a randomized, double-blind, placebo-controlled clinical trial.
    Dowson AJ; Massiou H; Laínez JM; Cabarrocas X
    Cephalalgia; 2002 Jul; 22(6):453-61. PubMed ID: 12133045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Almotriptan, a new anti-migraine agent: a review.
    Gras J; Llenas J; Jansat JM; Jáuregui J; Cabarrocas X; Palacios JM
    CNS Drug Rev; 2002; 8(3):217-34. PubMed ID: 12353056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC; Gendolla A; Gebert I; Beneke M
    Eur Neurol; 2005; 53 Suppl 1():41-8. PubMed ID: 15920337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of subcutaneous almotriptan for the treatment of acute migraine: a randomized, double-blind, parallel-group, dose-finding study.
    Cabarrocas X;
    Clin Ther; 2001 Nov; 23(11):1867-75. PubMed ID: 11768838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerability and efficacy of almotriptan in the long-term treatment of migraine.
    Pascual J; Falk R; Docekal R; Prusinski A; Jelencsik J; Cabarrocas X; Segarra X; Luria X; Ferrer P
    Eur Neurol; 2001; 45(4):206-13. PubMed ID: 11385257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials.
    Ferrari MD; Roon KI; Lipton RB; Goadsby PJ
    Lancet; 2001 Nov; 358(9294):1668-75. PubMed ID: 11728541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of almotriptan malate for migraine.
    Balbisi EA
    Am J Health Syst Pharm; 2002 Nov; 59(22):2184-93. PubMed ID: 12455302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of almotriptan in controlled clinical trials.
    Mathew NT
    Eur Neurol; 2005; 53 Suppl 1():29-33. PubMed ID: 15920335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Almotriptan: a review of pharmacology, clinical efficacy, and tolerability.
    Von S
    Am J Manag Care; 2002 Feb; 8(3 Suppl):S74-9. PubMed ID: 11859907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral almotriptan: practical uses in the acute treatment of migraine.
    Dowson AJ
    Expert Rev Neurother; 2004 May; 4(3):339-48. PubMed ID: 15853532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.
    Ferrari MD; Goadsby PJ; Roon KI; Lipton RB
    Cephalalgia; 2002 Oct; 22(8):633-58. PubMed ID: 12383060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consistent efficacy and tolerability of almotriptan in the acute treatment of multiple migraine attacks: results of a large, randomized, double-blind, placebo-controlled study.
    Pascual J; Falk RM; Piessens F; Prusinski A; Docekal P; Robert M; Ferrer P; Luria X; Segarra R; Zayas JM
    Cephalalgia; 2000 Jul; 20(6):588-96. PubMed ID: 11075844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.